000 | 01672 a2200457 4500 | ||
---|---|---|---|
005 | 20250514020633.0 | ||
264 | 0 | _c20011231 | |
008 | 200112s 0 0 eng d | ||
022 | _a0008-543X | ||
024 | 7 |
_a10.1002/1097-0142(20011001)92:7<1888::aid-cncr1706>3.0.co;2-z _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNathan, C A | |
245 | 0 | 0 |
_aCOX-2 expression in dysplasia of the head and neck: correlation with elF4E. _h[electronic resource] |
260 |
_bCancer _cOct 2001 |
||
300 |
_a1888-95 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAnticarcinogenic Agents _xtherapeutic use |
650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xmetabolism |
650 | 0 | 4 | _aCyclooxygenase 2 |
650 | 0 | 4 | _aCyclooxygenase 2 Inhibitors |
650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aHead and Neck Neoplasms _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aIsoenzymes _xantagonists & inhibitors |
650 | 0 | 4 | _aMembrane Proteins |
650 | 0 | 4 |
_aPrecancerous Conditions _xdrug therapy |
650 | 0 | 4 |
_aProstaglandin-Endoperoxide Synthases _xmetabolism |
650 | 0 | 4 |
_aRespiratory Mucosa _xmetabolism |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aLeskov, I L | |
700 | 1 | _aLin, M | |
700 | 1 | _aAbreo, F W | |
700 | 1 | _aShi, R | |
700 | 1 | _aHartman, G H | |
700 | 1 | _aGlass, J | |
773 | 0 |
_tCancer _gvol. 92 _gno. 7 _gp. 1888-95 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(20011001)92:7<1888::aid-cncr1706>3.0.co;2-z _zAvailable from publisher's website |
999 |
_c11658271 _d11658271 |